Trial · NCT02355665
Registered outcomes214
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 214
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Percentage of Participants With Continuous Smoking Abstinence From Week 2 to Week 6 | Week 2 to Week 6 | Percentage of participants with carbon monoxide (CO)-verified self-report of continuous abstinence from smoking |
| Secondary | Percentage of Participants With Continuous Smoking Abstinence From Week 2 to Week 12 | Week 2 to Week 12 | Percentage of participants with carbon monoxide (CO)-verified self-report of continuous abstinence from smoking |
| Secondary | Percentage of Participants With Continuous Smoking Abstinence From Week 2 to Week 26 | Week 2 to Week 26 | Percentage of participants with carbon monoxide (CO)-verified self-report of continuous abstinence from smoking |
| Secondary | Percentage of Participants With Continuous Smoking Abstinence From Week 2 to Week 4 | Week 2 to Week 4 | Percentage of participants with carbon monoxide (CO)-verified self-report of continuous abstinence from smoking |
| Secondary | Percentage of Participants With Continuous Smoking Abstinence From Week 2 to Week 8 | Week 2 to Week 8 | Percentage of participants with carbon monoxide (CO)-verified self-report of continuous abstinence from smoking |
| Secondary | Percentage of Participants With Continuous Smoking Abstinence From Week 2 to Week 16 | Week 2 to Week 16 | Percentage of participants with carbon monoxide (CO)-verified self-report of continuous abstinence from smoking |
| Secondary | Percentage of Participants With Continuous Smoking Abstinence From Week 2 to Week 20 | Week 2 to Week 20 | Percentage of participants with carbon monoxide (CO)-verified self-report of continuous abstinence from smoking |
| Secondary | Percentage Distribution of the Rating of Desire/Urge to Smoke on a Categorical Scale at Week 1 | Week 1 | Participants were asked if during the last 24 hours they experienced the desire/urge to smoke on a 5-grade categorical scale of 0 - 4 (where 0=not at all and 4=extremely so). |
| Secondary | Percentage Distribution of the Rating of Desire/Urge to Smoke on a Categorical Scale at Week 2 | Week 2 | Participants were asked if during the last 24 hours they experienced the desire/urge to smoke on a 5-grade categorical scale of 0 - 4 (where 0=not at all and 4=extremely so). |
| Secondary | Percentage Distribution of the Rating of Desire/Urge to Smoke on a Categorical Scale at Week 4 | Week 4 | Participants were asked if during the last 24 hours they experienced the desire/urge to smoke on a 5-grade categorical scale of 0 - 4 (where 0=not at all and 4=extremely so). |
| Secondary | Percentage Distribution of the Rating of Desire/Urge to Smoke on a Categorical Scale at Week 6 | Week 6 | Participants were asked if during the last 24 hours they experienced the desire/urge to smoke on a 5-grade categorical scale of 0 - 4 (where 0=not at all and 4=extremely so). |
| Secondary | Percentage Distribution of the Rating of Irritability/Frustration/Anger on a Categorical Scale at Week 1 | Week 1 | Participants were asked if during the last 24 hours they experienced irritability/frustration/anger on a 5-grade categorical scale of 0 - 4 (where 0=not at all and 4=extremely so). |
| Secondary | Percentage Distribution of the Rating of Irritability/Frustration/Anger on a Categorical Scale at Week 2 | Week 2 | Participants were asked if during the last 24 hours they experienced irritability/frustration/anger on a 5-grade categorical scale of 0 - 4 (where 0=not at all and 4=extremely so). |
| Secondary | Percentage Distribution of the Rating of Irritability/Frustration/Anger on a Categorical Scale at Week 4 | Week 4 | Participants were asked if during the last 24 hours they experienced irritability/frustration/anger on a 5-grade categorical scale of 0 - 4 (where 0=not at all and 4=extremely so). |
| Secondary | Percentage Distribution of the Rating of Irritability/Frustration/Anger on a Categorical Scale at Week 6 | Week 6 | Participants were asked if during the last 24 hours they experienced irritability/frustration/anger on a 5-grade categorical scale of 0 - 4 (where 0=not at all and 4=extremely so). |
| Secondary | Percentage Distribution of the Rating of Restlessness on a Categorical Scale at Week 1 | Week 1 | Participants were asked if during the last 24 hours they experienced restlessness on a 5-grade categorical scale of 0 - 4 (where 0=not at all and 4=extremely so). |
| Secondary | Percentage Distribution of the Rating of Restlessness on a Categorical Scale at Week 2 | Week 2 | Participants were asked if during the last 24 hours they experienced restlessness on a 5-grade categorical scale of 0 - 4 (where 0=not at all and 4=extremely so). |
| Secondary | Percentage Distribution of the Rating of Restlessness on a Categorical Scale at Week 4 | Week 4 | Participants were asked if during the last 24 hours they experienced restlessness on a 5-grade categorical scale of 0 - 4 (where 0=not at all and 4=extremely so). |
| Secondary | Percentage Distribution of the Rating of Restlessness on a Categorical Scale at Week 6 | Week 6 | Participants were asked if during the last 24 hours they experienced restlessness on a 5-grade categorical scale of 0 - 4 (where 0=not at all and 4=extremely so). |
| Secondary | Percentage Distribution of the Rating of Difficulty Concentrating on a Categorical Scale at Week 1 | Week 1 | Participants were asked if during the last 24 hours they experienced difficulty concentrating on a 5-grade categorical scale of 0 - 4 (where 0=not at all and 4=extremely so). |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02355665/registered